tiprankstipranks
Advertisement
Advertisement

JB Chemicals Publishes NCLT-Directed Notice for Equity Shareholders’ Meeting

Story Highlights
  • JB Chemicals & Pharmaceuticals has advertised a notice convening a tribunal-ordered meeting of its equity shareholders.
  • The notice was published in national English and regional Gujarati newspapers, signaling a formal compliance step before potential corporate actions.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
JB Chemicals Publishes NCLT-Directed Notice for Equity Shareholders’ Meeting

Claim 55% Off TipRanks

The latest announcement is out from JB Chemicals & Pharmaceuticals Ltd. ( (IN:JBCHEPHARM) ).

JB Chemicals & Pharmaceuticals Ltd. has notified the stock exchange that it has published a newspaper advertisement giving notice of a meeting of its equity shareholders. The shareholder meeting has been convened pursuant to an order dated March 23, 2026, by the National Company Law Tribunal’s Ahmedabad Bench, and the notice has been carried in national English and regional Gujarati newspapers, underscoring a formal compliance step that may precede or support a significant corporate action requiring shareholder approval.

More about JB Chemicals & Pharmaceuticals Ltd.

JB Chemicals & Pharmaceuticals Ltd. is an Indian pharmaceutical company engaged in manufacturing and marketing formulations and active pharmaceutical ingredients. Its product portfolio typically spans prescription drugs and over-the-counter medicines, serving domestic and international markets through a range of branded and generic therapies.

Average Trading Volume: 14,060

Technical Sentiment Signal: Buy

Current Market Cap: 330.4B INR

See more data about JBCHEPHARM stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1